Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Alpha Cognition Inc.
Alpha Cognition Inc.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
No data
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Galantamine
malnutrition
,
healthy volunteers/patients
,
recurrence
,
insulin resistance
,
hypersensitivity
,
oxidative stress
,
smoking
,
fasting
,
postural orthostatic tachycardia syndrome
,
marijuana abuse
,
memory
,
pharmacokinetics
,
tobacco use disorder
,
cocaine-related disorders
,
obesity
,
inflammation
,
aids dementia complex
,
traumatic brain injuries
,
brain injuries
,
post-traumatic stress disorders
,
traumatic stress disorders
,
hemorrhage
,
subarachnoid hemorrhage
,
frontotemporal dementia
,
frontotemporal lobar degeneration
,
primary progressive aphasia
,
pick disease of the brain
,
brain diseases
,
mental disorders
,
vascular dementia
,
nervous system diseases
,
psychophysiologic disorders
,
anxiety disorders
,
somatoform disorders
,
vascular ring
,
major depressive disorder
,
autistic disorder
,
ischemic stroke
,
spinal cord injuries
,
quadriplegia
,
paraplegia
,
alzheimer disease
,
dementia
,
cognitive dysfunction
,
schizophrenia
,
cognition disorders
,
psychotic disorders
,
bipolar disorder
,
mixed dementias
,
depression
,
lewy body disease
,
stroke
,
neurocognitive disorders
,
metabolic syndrome
,
depressive disorder
,
parkinson disease
,
abdominal obesity
,
syndrome
,
tic disorders
,
tourette syndrome
,
tics
,
craniocerebral trauma
,
headache
,
memory disorders
,
post-traumatic headache
,
closed head injuries
,
attention deficit disorder with hyperactivity
,
tardive dyskinesia
,
dyskinesias
,
late onset disorders
,
central nervous system diseases
,
neurodegenerative diseases
,
tauopathies
,
caregiver burden
,
addictive behavior
,
aphasia
,
broca aphasia
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use